Novel transcript antisense to Laminin subunit alpha 1 (LOC101927188)

"Novel transcript, antisense to LAMA1" (ENSG00000265069, LOC101927188) is a long non-coding RNA transcribed on the opposite strand to the Laminin subunit alpha 1 (LAMA1) gene. Antisense transcripts may regulate the sense gene via effects on chromatin structure and transcription dynamics, including modulation of transcript stability and initiation rates. While LAMA1 is critical for extracellular matrix assembly, cell adhesion, and tissue development, particularly in ocular and fibrotic diseases, the functional significance of this antisense locus remains unclear, and there is presently no evidence it represents a classical therapeutic target or a validated clinical biomarker. The lack of characterization, functional validation, or recognized nomenclature implies that the entry is currently considered incomplete and not directly applicable for structured drug discovery efforts. ENSG00000265069 is not the LAMA1 gene itself (that is ENSG00000101680) but a novel, non-coding antisense transcript in the LAMA1 locus. Antisense transcripts generally play regulatory roles, such as modulating the expression, stability, or chromatin state of their sense counterparts. There is no established literature or drug development effort focused on ENSG00000265069 or LOC101927188 as a therapeutic target. The LAMA1 gene's protein product, Laminin subunit alpha 1, is better characterized with clear roles in extracellular matrix biology and disease.

Other names

LOC101927188ENSG00000265069Novel antisense transcript to LAMA1